Brief: Cynata Therapeutics Seeks Trading Halt
12/06/2026 24:47
BRIEF-Cynata Therapeutics Seeks Trading Halt June 12 (Reuters) - Cynata Therapeutics Ltd CYP.AX:
TRADING HALT PENDING PHASE 3 OSTEOARTHRITIS AND PHASE 2 GVHD TRIAL RESULTS
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million